Sabtu, 22 Februari 2025 (18:30)
Sabtu, 22 Februari 2025 (18:30)
 Music |
 Video |
 Movies |
 Chart |
 Show |
 | The CheckMate 816 Trial: The Success of Adjuvant NSCLC Therapies - Lung Cancer OncTalk 2022 (GRACE - Global Resource for Advancing Cancer Education) View |
 | Checkmate 816: Combining Chemo and Opdivo - ASCO Lung Review 2022 (GRACE - Global Resource for Advancing Cancer Education) View |
 | ASCO 2021 Lung Recap: Surgical Outcomes u0026 Checkmate 816: Nivolumab in Early Stage NSCLC (GRACE - Global Resource for Advancing Cancer Education) View |
 | KEYNOTE-091 and IMPOWER010: adjuvant chemotherapy for NSCLC (VJOncology) View |
 | Emerging Approaches to Small Cell Lung Cancer | 2022 Evolution Conference (Total Health | Oncology) View |
 | Refining which patients benefit from consolidation durvalumab for stage III unresectable NSCLC (VJOncology) View |
 | () View |
| () View |
| () View |
| () View |
